Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?

Premkumar, Madhumita; Grover, Gagandeep S; Dhiman, Radha K

Premkumar, Madhumita; Grover, Gagandeep S; Dhiman, Radha K.

Premkumar M; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
Grover GS; Program Officer, Hepatitis C Virus Infection, Punjab, India.
Dhiman RK; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

J Clin Exp Hepatol ; 7(3): 253-261, 2017 Sep.

Article en En | MEDLINE | ID: mdl-28970713

Palabras clave

ALT, alanine aminotransferase; CHC, chronic hepatitis C; CI, confidence interval; DAAs; DAAs, direct-acting antiviral agents; DCV, daclatasvir; EASL, The European Association for the Study of the Liver; GT, Genotype; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; IL, interleukin; INASL, Indian National Association for study of the Liver; LDV, ledipasvir; Peg-IFN, pegylated interferon; RBV, ribavirin; SOF, sofosbuvir; SVR, sustained virologic response; VEL, velpatasvir; chronic hepatitis C; generic direct antivirals; real life efficacy study

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Año: 2017 Tipo del documento: Article